Everyone Healthy Library
Chronic Lymphocytic Leukemia
Condition / disease reference page from the Everyone Healthy database.
Connected health information
Explore this condition in a clear order
Condition overview
Attributes
Linked signs and symptoms
5Each sign/symptom opens its own page and links back to related conditions.
Linked drugs / medications
10Medication information is educational only. A doctor or pharmacist should advise whether any medicine is appropriate.
Treatments, therapies and supportive options
15Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Medical therapy
1Alternative and complementary therapies
7- Germanium (Germanium Sesquioxide, Vitamin O)Strongly Against(Moderate Evidence)
- Licorice (Glycyrrhiza Glabra, Gan Cao)Weakly in Favour(Low Evidence)
- Mistletoe (Iscador, Viscum Album)No Recommendation(Low Evidence)
- Pau Darco (Lapachol, Tabebuia Impetiginosa, Tabebuia Heptaphylla)Strongly Against(Very Low Evidence)
- Rabdosia Rubescens (Dong Ling Cao, Oridonin, Isodon Rubescens)
- Uncaria tomentosa Plant (Cats Claw Herb)
- Vitae ElixxirNo Recommendation(Very Low Evidence)
Alternative medicine
5- Licorice (Glycyrrhiza Glabra, Gan Cao)Weakly in Favour(Low Evidence)
- Mistletoe (Iscador, Viscum Album)No Recommendation(Low Evidence)
- Pau Darco (Lapachol, Tabebuia Impetiginosa, Tabebuia Heptaphylla)Strongly Against(Very Low Evidence)
- Rabdosia Rubescens (Dong Ling Cao, Oridonin, Isodon Rubescens)Weakly in Favour(Low Evidence)
- Vitae ElixxirNo Recommendation(Very Low Evidence)
Vitamins and minerals
1Linked diagnostic tests and investigations
28These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
- Alkaline Phosphatase (ALP) Concentration
- Ammonia Concentration Test
- Bleeding Time (Ivy Method)
- Blood Uric Acid Concentration Test
- Calcium Concentration (Blood, Total)
- Cerebrospinal Fluid Lactic Dehydrogenase Concentration
- complete Blood Count (CBC)
- Eosinophils Count
- Euglobulin Lysis Time (Fibrinolysis Time)
- Ferritin Concentration
- Fetal Hemoglobin (Hemoglobin F, HbF) Concentration
- Fibrinogen Concentration test
- Fluid Deprivation Test
- Folic Acid (Folate) Concentration
- haptoglobin (Hp) concentration
- Heamatocrit (Hct)
- Hemoglobin (Hb) Concentration
- Lactate Dehydrogenase Concentration
- Lymphocyte Immunophenotyping
- Lymphocytes Count
- Neutrophil Absolute Count
- Platelet Aggregation Test
- Platelet Count
- Protein Electrophoresis (Blood, Serum Protein)
- Pyruvate Kinase (PK) Concentration in RBC
- Red Blood Cell (RBC) Count
- Vitamin B12 (VB12) Concentration
- White Blood Cell (WBC) Count
Biological and test markers
33This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
Often increased
19- Alkaline Phosphatase (ALP)Reference range exampleAdult ( > 16y), Female: 30–125 units/L; Adult ( > 16y), Male: 40–110 units/LLinked diagnostic tests1Alkaline Phosphatase (ALP) Concentration
- AmmoniaReference range exampleAdult ( > 16y): 6–48 µmol/LLinked diagnostic tests1Ammonia Concentration Test
- B Cells (CD19 Percentage)Reference range exampleAll: 3–25 %Linked diagnostic tests1Lymphocyte Immunophenotyping
- Calcium (Blood, Total)Reference range exampleAdult ( > 16y): 8.5–10.4 mg/dL; Birth - 2wks: 7.6–10.3 mg/dLLinked diagnostic tests1Calcium Concentration (Blood, Total)
- Cerebrospinal Fluid Lactate DehydrogenaseReference range exampleInfant (0 - 1y): 0–75 units/L; Adult ( > 16y): 0–40 units/LLinked diagnostic tests1Cerebrospinal Fluid Lactic Dehydrogenase Concentration
- FerritinReference range exampleChild (0 - 16y): 7–140 µg/L; Adult ( > 16y), Female: 18–160 µg/LLinked diagnostic tests1Ferritin Concentration
- Fetal Hemoglobin (Hemoglobin F, HbF)Reference range exampleAdult ( > 16y): 0–2.1 %; Birth - 2wks: 56–90 %Linked diagnostic tests1Fetal Hemoglobin (Hemoglobin F, HbF) Concentration
- haptoglobin (Hp)Reference range example45–200 mg/dLLinked diagnostic tests1haptoglobin (Hp) concentration
- Helper T cells (CD3(plus), CD4(plus))Reference range example589–1,505 cells/mm3; 32–61Linked diagnostic tests3Helper T cells (CD3(plus), CD4(plus)) Count
- Lactate Dehydrogenase (LDH)Reference range exampleInfant (0 - 1y): 120–250 units/L; Adult ( > 16y): 100–200 units/LLinked diagnostic tests1Lactate Dehydrogenase Concentration
- LymphocytesReference range exampleAdult ( > 16y): 25–40 %; 700–3,500 cells/mm3Linked diagnostic tests2Differential White Blood Cell Count Tests, Lymphocytes Count
- Natural Killer Cells (CD16 Percentage)Reference range exampleAll: 4–30 %Linked diagnostic tests1Lymphocyte Immunophenotyping
- PlateletsReference range exampleChild (0 - 16y): 150–450 109/L; Adult ( > 16y): 135–380 109/LLinked diagnostic tests1Platelet Count
- T-Suppressor (CD8) CellsReference range exampleAll: 15–40 %Linked diagnostic tests1Lymphocyte Immunophenotyping
- Template Bleeding TimeReference range exampleAdult ( > 16y): 2.5–9 MinutesLinked diagnostic tests1Bleeding Time (Ivy Method)
- Total T cells (CD3(plus))Reference range exampleAll: 55–90 %; 812–2,318 cells/mm3Linked diagnostic tests3Lymphocyte Immunophenotyping, Total T Cells (CD3(plus)) Count
- Uric Acid, BloodReference range exampleAdult ( > 16y), Female: 2.5–7 mg/dL; Adult ( > 16y), Male: 4–8 mg/dLLinked diagnostic tests1Blood Uric Acid Concentration Test
- Vitamin B12 (VB12)Reference range exampleAdult ( > 16y): 130–670 pmol/LLinked diagnostic tests1Vitamin B12 (VB12) Concentration
- White Blood Cell (WBC)Reference range exampleAdult ( > 16y): 4.5–10.5 million/mL; Adult ( > 16y): 3.2–10 million/mLLinked diagnostic tests1White Blood Cell (WBC) Count
Often decreased
14- Albumin (Blood)Reference range exampleAdult ( > 16y): 37–52 gm/dL; Infant (0 - 1y): 4.4–5.4 gm/dLLinked diagnostic tests2Blood Albumin Concentration, Protein Electrophoresis (Blood
- Beta GlobulinReference range exampleAll: 0.7–1.2 gm/dLLinked diagnostic tests1Protein Electrophoresis (Blood, Serum Protein)
- Complete Platelet Aggregation in Response to Collagen, Thrombin, RistocetinReference range exampleAll: 0–1 PresentLinked diagnostic tests1Platelet Aggregation Test
- EosinophilsReference range exampleAdult ( > 16y): 0–3 %; 0–3 %Linked diagnostic tests3Differential White Blood Cell Count Tests, Eosinophil Differential Of Total WBC
- FibrinogenReference range exampleAdult ( > 16y): 150–400 mg/dLLinked diagnostic tests1Fibrinogen Concentration test
- Folic Acid (Folate)Reference range exampleInfant (0 - 1y): 14–51 ng/mL; Child (0 - 16y): 5–21 ng/mLLinked diagnostic tests1Folic Acid (Folate) Concentration
- Gamma Globulin (Blood, Serum)Reference range exampleAll: 0.8–1.7 gm/dLLinked diagnostic tests1Protein Electrophoresis (Blood, Serum Protein)
- Hemoglobin (Hb)Reference range exampleFemale: 78–100 gm/dL; Male: 76–100 gm/dLLinked diagnostic tests3Hemoglobin (Hb) Concentration, Mean Corpuscular Hemoglobin (MCH) Weight Test
- Plasma Clot Lysis TimeReference range exampleAll: 120–600 MinutesLinked diagnostic tests1Euglobulin Lysis Time (Fibrinolysis Time)
- Protein, Total (Blood, Serum)Reference range exampleInfant (0 - 1y): 6–6.7 gm/dL; Child (0 - 16y): 6.1–8.2 gm/dLLinked diagnostic tests1Protein Electrophoresis (Blood, Serum Protein)
- Pyruvate Kinase (PK)Reference range example2.75–8.7 µmol/gLinked diagnostic tests1Pyruvate Kinase (PK) Concentration in RBC
- RBC MassReference range exampleFemale: 36–48 %; Male: 42–52 %Linked diagnostic tests1Heamatocrit (Hct)
- Red Blood Cells (RBC)Reference range exampleAdult ( > 16y), Female: 3.6–5 106/mm3; Adult ( > 16y), Male: 4.2–5.4 106/mm3Linked diagnostic tests1Red Blood Cell (RBC) Count
- Segmented NeutrophilsReference range exampleAdult ( > 16y): 50–62 %; Adult ( > 16y): 2,500–8,000 mm3Linked diagnostic tests2Differential White Blood Cell Count Tests, Neutrophil Absolute Count
Other associated markers
0No markers in this group.
Introduction / full article
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is an abnormal proliferation of a particular type of white blood cells termed lymphocytes hence its name. [1] Moreover, the condition is chronic which means that it progresses slowly. [2] The onset is often insidious. [3]
Epidemiology
CLL is the most frequent form of leukemia occurring among adult individuals in the Western nations. The condition is atypical in Asian countries. There is male predilection and reports state that the incidence is higher in whites. The elder population seems to be the mostly affected with a median age of 72 years old. [3] The condition is also more seen in certain races like the Jewish people of Russian or East European descent. [1]
Causes
The exact cause is unknown. True familial cases are rare. [3] Experts could not establish the association of CLL to radiation, chemicals or viruses. [1]
Signs and Symptoms
Signs and symptoms develop gradually. These include enlarged lymph node, liver or spleen. The enlarged lymph nodes may be located in the neck, armpit or in the groin area. An enlarged liver may manifest as pain or discomfort in the upper right part of the abdomen while an enlarged spleen may manifest as pain or discomfort in the upper left side under the ribs. A person with CLL may lose appetite and experience fatigue. Paleness and persistent tiredness are common. The patient can experience excessive sweating especially at night, fever and recurrent infections. There can be easy bruising, easy bleeding and pinpoint rashes in the skin called petechiae. Unintentional weight loss is another nonspecific symptom of CLL. [1] [3] [4]
Diagnosis
Adequate medical history coupled with physical examination is required to suspect CLL. To make an accurate diagnosis, laboratory exams are needed such as complete blood count and bone marrow biopsy. Other tests include CT scan, immunoglobulin tests and flow cytometry tests. [1] To help predict the outlook or clinical course, chromosomal tests can be employed. [2]
Treatment
Patients in the early stages often do not need treatment. Medical intervention is only suggested for those whose disease has progressed or is causing significant symptoms. Chemotherapy drugs like fludarabine may be used. Depending on the case, transfusion of blood or blood component may be required. The only known curative therapy is transplant. [1] [3]
References:
1. http://www.nlm.nih.gov/medlineplus/ency/article/000532.htm
2. http://www.mayoclinic.com/health/chronic-lymphocytic-leukemia/DS00565
3. http://emedicine.medscape.com/article/199313-overview#aw2aab6b2b2
4. http://www.leukaemia.org.au/web/aboutdiseases/leukaemias_cll.php
Efficacy of Alternative and Other Treatments According to GRADE* Ranking:
Vitae Elixxir[1, 21, 22]:
Please note, this management does NOT treat the condition itself. It is proposed only as a weak supportive symptomatic support, and even then, has insufficient evidence to back up this claim at present. Warning: Possible side effects of Vitae Elixxir include diarrhoea, pain, and a general worsening of existing symptoms.
Recommendation: No recommendation (Available evidence does not support claims that vitae elixir helps to treat leukemia)
Grade of Evidence: very low quality of evidence
Rabdosia Rubescens (Dong Ling Cao, Oridonin, Isodon Rubescens) [1, 15, 16, 17, 18, 19, 20]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present.
Recommendation: weakly in favor (Laboratory studies show that rabdosia rubescens has anti-cancer activity, and may be helpful in the treatment of leukemia. However, more studies are needed)
Grade of Evidence: low quality of evidence
* www.gradeworkinggroup.org
Pau D'Arco (Lapachol, Tabebuia Impetiginosa, Tabebuia Heptaphylla) [1, 14]:
Please note, this treatment has potentially serious side effects. Some of the chemicals in the plant are known to be toxic. High doses are known to cause liver and kidney. Even at low doses, chemicals in the plant may interfere with blood clotting, causing excess bleeding and anaemia. Pau D'Arco should be avoided, especially by pregnant or breastfeeding women.
Recommendation: Strongly against (There is insufficient evidence to support claims that Pau D'arco helps to treat leukemia. This, combined with its potentially harmful side effects if taken without supervision from a doctor or pharmacist gives enough reason to avoid this treatment.)
Grade of Evidence: very low quality of evidence
Mistletoe (Iscador, Viscum Album) [1, 9, 10, 11, 12, 13]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present. WARNING: The mistletoe plant should NOT be eaten because it is poisonous. May cause seizures, coma and death. It should only be taken as a purified mistletoe extract, and only in recommended doses.
Recommendation: No recommendation (Studies on the effect of Mistletoe on Leukemia have yielded mixed, conflicting results. More research is needed.)
Grade of Evidence: low quality of evidence
Licorice (Glcyrhiz Gaba) [1, 5, 6, 7, 8]:
Please note, this management does NOT treat the condition itself. It may mildly help with some of the symptoms, and even then has insufficient evidence to back up this claim at present. Licorice has been shown to have potentially harmful side effects in people with high blood pressure, liver or kidney diseases)
Recommendation: Weakly in favor (Small studies and laboratory tests show that Licorice may help reduce tumor growth in leukemia, but more research is needed)
Grade of Evidence: low quality of evidence
Germanium (Germanium Sesquioxide, Vitamin O) [1, 2, 3, 4]:
WARNING: Germanium may cause permanent Kidney failure. Even organic supplements, though less toxic than inorganic supplements, have caused kidney and liver damage. NOT TO BE USED.
Recommendation: strongly against (Evidence shows that Germanium is not effective in treating Leukemia in any way, and is also toxic, causing severe kidney and liver damage.)
Grade of Evidence: moderate quality of evidence
* www.gradeworkinggroup.org